Latest news with #ReverseShoulderArthroplastySystems
Yahoo
10-03-2025
- Business
- Yahoo
Shoulder Innovations secures $40m to advance arthroplasty systems
Shoulder Innovations has secured $40m in a Series E equity financing round, to mainly progress the commercialisation of its InSet Total Shoulder and Reverse Shoulder Arthroplasty Systems. The proceeds from the round will also be utilised for general corporate activities and supporting the development of a new product. Current investor US Venture Partners led the funding round, which also saw contributions from current investors such as Gilde Healthcare Partners, Aperture Venture Partners, and Gilmartin Capital, along with Sectoral Asset Management and Arboretum Ventures. Shoulder Innovations CEO Rob Ball said: 'Over recent years, we have significantly expanded our product line, strengthened our sales organisation, and emerged as a pure-play leader in shoulder arthroplasty. 'We appreciate the support of our new and existing investors and see this financing as well-timed as we hone our focus on accelerating commercial momentum and advance our mission of enabling best-in-class outcomes for shoulder specialists and their patients.' The company noted that InSet Glenoid technology is tailored to mitigate glenoid loosening, the primary cause of failure in total shoulder arthroplasty (TSA). By positioning the implant within a sclerotic bone pocket, the InSet Glenoid claims to decrease mechanical stress at the interface of bone and implant, which has been demonstrated through finite element analysis to lessen "rocking horse" stresses by 87%. This method aids surgeons in improving the shoulder implants' longevity. According to the company, the InSet Reverse System provides a reproducible solution for complex shoulder condition management while maintaining biomechanical integrity. Shoulder Innovations focuses on advancing shoulder arthroplasty solutions and aims to enhance patient care and minimise healthcare expenses. "Shoulder Innovations secures $40m to advance arthroplasty systems" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
Associated Press
10-03-2025
- Business
- Associated Press
Shoulder Innovations Announces Closing of $40 Million Series E Equity Financing
GRAND RAPIDS, Mich., March 10, 2025 /PRNewswire/ -- Shoulder Innovations, a leader in shoulder replacement technology, today announced the closing of a $40 million Series E equity financing round. The financing was led by existing investor U.S. Venture Partners (USVP), with support from additional existing investors including Gilde Healthcare Partners, Gilmartin Capital, and Aperture Venture Partners. New investors Arboretum Ventures and Sectoral Asset Management also participated. Proceeds from the financing will be used primarily to advance commercialization of the Company's InSet™ Total Shoulder and Reverse Shoulder Arthroplasty Systems and support new product development, as well as for general corporate purposes. 'Over recent years, we have significantly expanded our product line, strengthened our sales organization, and emerged as a pure-play leader in shoulder arthroplasty,' said Rob Ball, CEO of Shoulder Innovations. 'We appreciate the support of our new and existing investors and see this financing as well-timed as we hone our focus on accelerating commercial momentum and advance our mission of enabling best-in-class outcomes for shoulder specialists and their patients.' 'Shoulder Innovations has established compelling clinical credibility with its disruptive and highly differentiated InSet™ technology, and U.S. Venture Partners is pleased to continue supporting the Company by leading this financing round,' said Casey Tansey, General Partner at U.S. Venture Partners. 'Looking ahead, we believe Shoulder Innovations is well-positioned to further advance patient outcomes while delivering economic benefits to healthcare practitioners as a leading innovator in the shoulder arthroplasty market.' About Shoulder Innovations: Shoulder Innovations is a shoulder arthroplasty-focused medical device development company that designs and commercializes innovative products that demonstrate the potential for improved patient care and reduced overall cost to the healthcare system. Leveraging its breakthrough, patented InSet™ glenoid design, Shoulder Innovations developed a shoulder replacement implant system focused on improving outcomes related to the greatest cause of anatomic shoulder replacement failure: glenoid loosening. The InSet™ technology has been shown in testing to significantly reduce glenoid implant micro-motion and simplifies the surgical technique, potentially reducing complications or increasing implant longevity. Beyond addressing one of the biggest problems in anatomic shoulder arthroplasty, Shoulder Innovations has also developed the anatomic reverse shoulder system, designed to work with and maximize the available rotator cuff instead of substituting for it.
